- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
USV kickstarts dedicated new plant in Baddi, HP
"This modern facility is of strategic importance to serve Indians to keep their heart healthy by offering a lifesaving quality brand at an affordable price," said Leena Gandhi Tewari at the plant inauguration.
Baddi: USV, an Indian multinational healthcare company, has announced the opening of a dedicated new manufacturing plant in Baddi, Himachal Pradesh.
"The new dedicated facility will improve access to high quality and affordable Ecosprin AV and further strengthen its leadership in the cardiology segment. With this new facility, the product will now be available in a more patient friendly pack," USV said in a release.
There are an increasing number of cases of cardiac events in our country even for younger individuals. Aspirin and Atorvastatin play a vital role in heart health to protect patients from cardiac events.
The plant was inaugurated by Mr Debabrata Bhadury, Director, USV in the presence of USV Chairperson Ms. Leena Gandhi Tewari and Managing Director Mr Prashant Tewari.
“This modern facility is of strategic importance to serve Indians to keep their heart healthy by offering a lifesaving quality brand at an affordable price”, said Leena Gandhi Tewari at the plant inauguration.
Mr Prashant Tewari, Managing Director said “This new unit at Baddi will contribute further to our responsibility of saving lives through offering quality medicines.”
The plant uses high-tech machinery and advanced technology in manufacturing and automated process checks to assure product quality and efficacy. The plant has many green initiatives like renewable energy usage, rainwater harvesting, and tree plantation already incorporated, right from inception.
M M Venkatachalam, Director USV said “The facility is very impressive and upgraded in terms of technology used, automation, QC, testing and sustainability practice. In the recent past USV has made great strides in new facilities, technologies, efficiencies, and capacities.”
Established in 1961, USV Private Limited is a Indian multinational healthcare companies with a presence in 65+ countries, with its products. USV’s global product offerings include Active Pharmaceutical Ingredients (APIs), generics, branded generics, Peptides, and Biosimilars.
Read also: USV Launches INSUQUICK, First Biosimilar Insulin Aspart in India
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751